Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new study from scientists at the Radcliffe Department of Medicine and Harvard Medical School, and funded by the British Heart Foundation, has uncovered a potential new treatment for hypertrophic cardiomyopathy (HCM).

Graphics of a heart with double helix in the background. © Image by kjpargeter on Freepik

HCM is a condition where the heart muscle becomes abnormally thick, making it harder for the heart to pump blood. It affects 1 in 250 people and is a leading cause of sudden cardiac death. The thickening is often caused by mutations in genes related to the heart’s muscle fibres, and over time can lead to scarring (fibrosis), heart failure, or even death.

The genetic roots of HCM have been understood for years, but we are yet to understand why the heart gets so scarred. The new study suggests that part of the answer lies in the body’s immune response.

The immune system’s surprising role

When researchers examined the hearts of deceased HCM patients and animal models with the disease, they found that immune cells had gathered in scarred areas of the heart, particularly in later stages of the disease.

‘These cells, usually known for fighting infections, were playing complex roles in either enhancing or limiting inflammation and scarring,’ said the Radcliffe Department of Medicine’s Ying-Jie Wang, first author of the paper.

‘In particular, we found that immune cells called macrophages, and other myeloid cells were highly active in diseased hearts, but another type of immune cell, called regulatory T cells (or Tregs), appeared to help limit the fibrosis and inflammation.’

 

Read the full story on the Radcliffe Department of Medicine website.

 

 

Similar stories

Prehistoric teeth used to create historic map of infectious diseases

A research project led jointly by researchers from the University of Oxford, the University of Copenhagen and University of Cambridge shows that large-scale mapping of prehistoric teeth and bones provides new knowledge of present-day infectious diseases. This may, among other things, have an impact on the development of vaccines.